Syndicate content

Add new comment

Submitted by Patricio V Marquez on

As noted on the blog, on the basis of needs assessments, one would need to adjust and adapt these estimates to emergency contexts. The study done by Chisholm et al (2016)included key categories of resource use: medication: 6 months continual antidepressant drug (generics)for moderate to severe cases; outpatient and primary care: regular visits for all cases, ranging from four per case per year for basic psychosocial treatment, up to 14–18 visits for moderate to severe cases receiving antidepressant drug and intensive psychosocial treatment (half of whom are assumed to receive this on an individual basis, the other half in groups). It was assumed that this care and follow-up would largely be undertaken in non-specialist health care settings by doctors, nurses and psychosocial care providers trained in the identification, assessment, and management of depression and anxiety disorders; and
inpatient care: few cases are expected to be admitted to hospital (2–3% of moderate to severe cases only, for an average length of stay of 14 days). Estimation also included expected level of program costs and shared health system resources needed to deliver interventions as part of integrated model of chronic disease management. These include program management and administration, training and supervision, drug safety monitoring, health promotion and awareness campaigns, and strengthened
logistics and information systems. The latter were estimated as on-cost to the estimated direct healthcare costs. The baseline value for on-cost was 10%
(and therefore grows in absolute terms during scale-up).